Emerald

Investor: Boost Capital Partners

Emerald has secured a £1.4 million Pre-Seed investment led by Boost Capital Partners, bringing its total pre-seed funding to $2M (£1.4M). Summary of transaction details: Value: £1.4 million Sector: Healthcare & Biotech Advisor: Not disclosed Key Entities: Emerald, Boost Capital Partners Location: London, UK Note: This investment marks a significant milestone in the preventive health revolution, and is expected to drive innovation and growth in the healthcare sector.

Investor: Harry Glorikian, Mike Benchimol, Patrick Bamford, Mart Abramov, Nikolay Tretiakov, Johann Huber, Jane Austin, several General Partners